Publication
Essential Corporate News: Week ending December 3, 2021
On November 26, 2021 the Financial Conduct Authority (FCA) published Policy Statement PS21/16, summarising feedback to a Consultation Paper (CP21/25) it published in July 2021
Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases
Global | Publication | April 2016
Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:
- regulatory matters;
- patent validity and damages;
- Patented Medicines (Notice of Compliance) Regulations proceedings; and
- class actions.
In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.
Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)
Contact
Partner, Lawyer, Trademark Agent, Patent Agent
Recent publications
Publication
Top EU court bans investors from suing member states in arbitration
Recent decisions by the Court of Justice of the European Union (CJEU), the EU’s top court, have abolished the rights that EU investors previously had to bring claims against EU member states in international arbitration.
Subscribe and stay up to date with the latest legal news, information and events...